HER-2阴性乳腺癌合并腋窝淋巴结转移新辅助化疗肿瘤退缩模式的影响因素
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

青岛大学医疗集团科研专项项目(YLJT20202020)


Analysis of influencing factors of tumor regression pattern of neoadjuvant chemotherapy in HER2-negative breast cancer with axillary lymph node metastasis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 了解人表皮生长因子受体-2(HER-2)阴性乳腺癌合并腋窝淋巴结转移的肿瘤退缩模式并分析其影响因素。方法 回顾性分析青岛大学医学院附属医院乳腺病诊疗中心2017年7月—2021年7月诊治的129例HER2阴性乳腺癌合并腋窝淋巴结转移病例,分析肿瘤退缩模式的影响因素。单因素、多因素分析分别采用χ2检验、二元回归分析。结果 HER2阴性、腋窝淋巴结转移乳腺癌,向心性退缩占62.02%,非向心性退缩占37.98%。单因素和多因素分析均显示,肿瘤分期与退缩模式差异有统计学意义(P<0.05) 。结论 原发肿瘤越大、浸润程度越深,非向心性退缩可能性越大。临床中对于cT4的原发肿瘤,新辅助治疗后选择保乳手术应慎重

    Abstract:

    Objective To investigate the tumor regression pattern of human epidermal growth factor receptor 2 (HER2) negative breast cancer with axillary lymph node metastasis and analyze its influencing factors. Methods A retrospective analysis was performed on 129 cases of HER2-negative breast cancer with axillary lymph node metastasis diagnosed and treated in the department of breast center of the Affiliated Hospital of Qingdao University from July 2017 to July 2021, and analyzed the influencing factors of tumor regression pattern.χ2 test was used for univariate analysis and binary regression was used for multivariate analysis. Results In HER2-negative breast cancer with axillary lymph node metastasis, 62.02% of breast cancer patients had centralistic regression, 37.98% had non-centralistic regression. Univariate and multivariate analysis showed that there were significant differences in tumor stage and regression mode (P<0.05)Conclusion The larger the primary tumor, the deeper the invasion, the greater the possibility of non - centripetal regression. In clinical practice, breast-conserving surgery should be carefully selected after neoadjuvant therapy for cT4 primary tumors

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-05-20
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司